Nano-X Imaging (NNOX) CEO Meltzer details option grants and shares

Rhea-AI Filing Summary

Nano-X Imaging Ltd. disclosed the initial holdings of Chief Executive Officer Erez Meltzer. He directly holds 60,584 ordinary shares. He also holds stock options over 40,234 ordinary shares at an exercise price of $2.2100 per share expiring on February 11, 2030, and options over 300,000 ordinary shares at $23.8400 per share expiring on January 2, 2032, both fully vested and exercisable. Additional options over 150,000 ordinary shares at $11.5200 per share expire on April 16, 2034 and vest over four years, with 25% vested after one year and 6.25% vesting quarterly until April 16, 2028.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Meltzer Erez

(Last) (First) (Middle)

C/O NANO-X IMAGING LTD., OFER TECH PARK

94 SHLOMO SHMELTZER ROAD

(Street)

PETACH TIKVA 4970602

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	60,584	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)	(1)	02/11/2030	Ordinary shares	40,234	$2.21	D
Stock Option (right to buy ordinary shares)	(2)	01/02/2032	Ordinary shares	300,000	$23.84	D
Stock Option (right to buy ordinary shares)	(3)	04/16/2034	Ordinary shares	150,000	$11.52	D

Explanation of Responses:

1. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.

2. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.

3. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).

Remarks:

Exhibit 24.1 Power of Attorney

	/s/ Marina Gofman Feler, attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Nano-X Imaging (NNOX) Form 3 reveal about CEO Erez Meltzer's share ownership?

The Form 3 shows CEO Erez Meltzer directly holds 60,584 ordinary shares of Nano-X Imaging. It also details several stock option grants over additional ordinary shares with specified exercise prices, vesting schedules, and expiration dates, outlining his total potential equity exposure.

What stock options does Nano-X Imaging (NNOX) CEO Erez Meltzer hold according to the Form 3?

Erez Meltzer holds options over 40,234 ordinary shares at $2.2100, 300,000 shares at $23.8400, and 150,000 shares at $11.5200. Each grant has its own expiration date and vesting terms, defining when these options can be exercised.

Are Nano-X Imaging (NNOX) CEO Erez Meltzer’s stock options fully vested?

Two option grants, for 40,234 and 300,000 ordinary shares, are fully vested and exercisable as of the Form 3 date. A third grant for 150,000 shares vests over four years, with all options fully vested by April 16, 2028.

When do Nano-X Imaging (NNOX) CEO Erez Meltzer’s stock options expire?

The options over 40,234 shares at $2.2100 expire on February 11, 2030. The 300,000 share grant at $23.8400 expires on January 2, 2032, and the 150,000 share grant at $11.5200 expires on April 16, 2034.

Does the Nano-X Imaging (NNOX) Form 3 show any recent insider buying or selling by CEO Erez Meltzer?

The Form 3 is an initial ownership report and lists Erez Meltzer’s existing holdings and option grants. It does not record open-market purchases or sales; instead, it establishes his baseline equity position and derivative awards as of the reporting date.